202
Participants
Start Date
April 22, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
BOTOX
Intramuscular Injections
Placebo
Intramuscular Injections
Edwin F. Williams III, MD FACS of LATHAM P.C. D/B/A THE REJUVA CENTER /ID# 248887, Latham
SkinDC /ID# 248885, Arlington
Wilmington Dermatology Center /ID# 250651, Wilmington
Total Skin and Beauty Dermatology Center /ID# 248218, Birmingham
Centricity Research Dublin Multispecialty /ID# 248484, Dublin
Clarkston Dermatology /ID# 248888, Clarkston
Coleman Center For Cosmetic Dermatologic Surgery /ID# 249827, Metairie
Delricht Research /ID# 249825, New Orleans
Dallas Plastic Surgery Institute /ID# 248220, Dallas
Bellaire Dermatology Associates /ID# 248221, Bellaire
Austin Institute for Clinical Research - Pflugerville /ID# 248217, Pflugerville
Mayo Clinic Arizona /ID# 248883, Phoenix
Skin Care and Laser Physicians of Beverly Hills /ID# 248223, Los Angeles
Cosmetic Laser Dermatology /ID# 248215, San Diego
Ava T. Shamban MD - Santa Monica. /ID# 248886, Santa Monica
DMR Research PLLC /ID# 248485, Westport
Susan H. Weinkle MD /ID# 252063, Bradenton
Skin and Cancer Associates, LLP /ID# 248209, Miami
Skin Laser and Surgery Specialists of NY and NJ /ID# 251501, Hackensack
Tennessee Clinical Research Center /ID# 248486, Nashville
Lead Sponsor
AbbVie
INDUSTRY